CSF and plasma BDNF levels were significantly lower in glioma patients than in the control group. The level of BDNF in tumor tissue did not differ significantly depending on IDH1 mutation status or other factors such as age, smoking, or medication use. The gene discussed is IDH1; the disease is central nervous system cancer.